NEW YORK (GenomeWeb) – Microbial genetics analysis firm OpGen said in a regulatory document that it has raised more than $1.2 million toward a targeted $1.5 million private financing round. 

Through a spokesperson, the Gaithersburg, Md.-based firm declined to comment. OpGen said in a document filed with the US Securities and Exchange Commission that there were nine investors in the round, but did not identify them. It also did not say how the funds would be used. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.